Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1 to 50 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
450.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 1 (sec7 homolog b2-1). [source:swissprot;acc:q15438]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho-related btb domain-containing protein 2 (deleted in breast cancer 2 gene protein) (p83). [source:swissprot;acc:q9byz6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
450.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
3\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 2 (arf nucleotide-binding site opener) (arno protein) (arf exchange factor). [source:swissprot;acc:q99418]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hlx1 (homeobox protein hb24). [source:swissprot;acc:q14774]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2597.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
698.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.71868\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
4\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hbs1-like. [source:refseq;acc:nm\_006620]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2597.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
698.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.71868\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
5\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
339.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
6\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
44490.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
36927.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7563\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
7\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
339.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
8\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
9\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
10\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
398.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
11\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
12\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 4. [source:refseq;acc:nm\_030627]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
34190.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
40795.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6604.9\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
6313\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6313\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6088.2\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.96739\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
6086.8\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
24250\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18164.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6085.1\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23421.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17580.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5841.1\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca3. [source:refseq;acc:nm\_138703]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.21818\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1833.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
892.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.0534\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5430.7\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/